Rating: Strong Buy
Danaher Financial Health
Profitability:6.79/10
❌ Danaher has worst Profitability than 55.56% of the companies on the Medical Diagnostics & Research industry
Net Margin: 17.9%
✅ Danaher has better Net Margin than 77.78% of the companies on the Medical Diagnostics & Research industry
ROE (Return on Equity): 2.72%
❌ Danaher has worst ROE (Return on Equity) than 62.5% of the companies on the Medical Diagnostics & Research industry
ROA (Return on Assets): 1.34%
❌ Danaher has worst ROA (Return on Assets) than 55.56% of the companies on the Medical Diagnostics & Research industry
Operating Efficiency:7.41/10
✅ Danaher has better Operating Efficiency than 60% of the companies on the Medical Diagnostics & Research industry
Operating Margin: 17.47%
✅ Danaher has better Operating Margin than 60% of the companies on the Medical Diagnostics & Research industry
Liquidity:7.85/10
❌ Danaher has worst Liquidity than 50% of the companies on the Medical Diagnostics & Research industry
Quick Ratio: 2.08
❌ Danaher has worst Quick Ratio than 50% of the companies on the Medical Diagnostics & Research industry
Operating Cash Flow Ratio: 0.82
✅ Danaher has better Operating Cash Flow Ratio than 70% of the companies on the Medical Diagnostics & Research industry
Solvency:7.64/10
✅ Danaher has better Solvency than 90% of the companies on the Medical Diagnostics & Research industry
Debt to Equity Ratio: 0.57
✅ Danaher has better Debt to Equity Ratio than 80% of the companies on the Medical Diagnostics & Research industry
Interest Coverage Ratio: 0.82
✅ Danaher has better Interest Coverage Ratio than 70% of the companies on the Medical Diagnostics & Research industry